Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Clinical use: Supervised protocols at medical clinics involve subcutaneous injection over 4 to 8 weeks, with dosing individualized to injury type and severity
Frontiers in Endocrinology, 17
MicroRNA 29b functions in acute myeloid leukemia
What to Expect: Week-by-Week Timeline Week 12: Early phase Reduced pain and inflammation (especially from TB-500's anti-inflammatory effects) Possible mild increase in heat or redness at the injury site (angiogenesis starting) Sleep may improve if the injury was affecting rest Week 34: Loading effects compound Noticeable reduction in chronic pain Range of motion beginning to improve Tendon/ligament stiffness decreasing Activity tolerance increasing Week 56: Maintenance phase begins Pain continues trending down Strength returning as tissue repairs Daily activities becoming easier Week 78: Evaluation point 6080% improvement is typical for acute injuries Chronic issues may need 1012 weeks for full effect Decision point: continue, taper, or add supportive therapies Common Stacking Questions Q: Should I take days off
We moved away from IV because intracellular NAD+ levels, which is where the benefit actually happens, do not reliably increase with IV administration
Recommended for individuals who wish to maintain general wellbeing
US$ 28.52
US$ 24.31
US$ 27.27
US$ 23.39
US$ 21.68
US$ 28.12
US$ 22.66
